best thing about is the lack of volume on the offer, just small parcels being hoovered at the moment. Whoever is wanting a piece still has a couple chunky bids sitting at 17 & 16.5c.
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
